Follow
Nicholas Easom
Nicholas Easom
Hull University Teaching Hospitals
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
Dexamethasone in hospitalized patients with Covid-19
RECOVERY Collaborative Group
New England Journal of Medicine 384 (8), 693-704, 2021
27222021
Effect of hydroxychloroquine in hospitalized patients with Covid-19
RECOVERY Collaborative Group
New England Journal of Medicine 383 (21), 2030-2040, 2020
14432020
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 397 (10285), 1637-1645, 2021
14312021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
13102021
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ...
The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021
4562021
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion
D Peppa, US Gill, G Reynolds, NJW Easom, LJ Pallett, A Schurich, ...
Journal of Experimental Medicine 210 (1), 99-114, 2013
3592013
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RC Group, PW Horby, M Mafham, L Peto, M Campbell, G Pessoa-Amorim, ...
MedRxiv, 2021.06. 15.21258542, 2021
320*2021
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
E Abaleke, M Abbas, S Abbasi, A Abbott, A Abdelaziz, S Abdelbadiee, ...
The Lancet 397 (10274), 605-612, 2021
3132021
IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection
LJ Pallett, J Davies, EJ Colbeck, F Robertson, N Hansi, NJW Easom, ...
Journal of Experimental Medicine 214 (6), 1567-1580, 2017
3092017
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ...
The Lancet Respiratory Medicine 10 (8), 761-775, 2022
2772022
Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission
PJ Lillie, A Samson, A Li, K Adams, R Capstick, GD Barlow, N Easom, ...
Journal of Infection 80 (5), 578-606, 2020
2392020
Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D
L Bacon, RA Eagle, M Meyer, N Easom, NT Young, J Trowsdale
The Journal of Immunology 173 (2), 1078-1084, 2004
2272004
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...
The Lancet 400 (10349), 359-368, 2022
2082022
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 397 (10289), 2049-2059, 2021
1102021
Lessons for managing high-consequence infections from first COVID-19 cases in the UK
P Moss, G Barlow, N Easom, P Lillie, A Samson
The Lancet 395 (10227), e46, 2020
992020
IL-15 overcomes hepatocellular carcinoma-induced NK cell dysfunction
NJW Easom, KA Stegmann, L Swadling, WC Huang, MK Maini
Frontiers in immunology 9, 360575, 2018
872018
Physical, cognitive and mental health impacts of COVID-19 following hospitalisation–a multi-centre prospective cohort study
PHOSP-COVID Collaborative Group, RA Evans, H McAuley, EM Harrison, ...
MedRxiv, 2021.03. 22.21254057, 2021
782021
Sixty‐eight consecutive patients assessed for COVID‐19 infection: experience from a UK regional infectious diseases unit
N Easom, P Moss, G Barlow, A Samson, T Taynton, K Adams, M Ivan, ...
Influenza and other respiratory viruses 14 (4), 374-379, 2020
692020
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ...
EBioMedicine 87, 2023
542023
T cells infiltrating diseased liver express ligands for the NKG2D stress surveillance system
WC Huang, NJ Easom, XZ Tang, US Gill, H Singh, F Robertson, C Chang, ...
The Journal of Immunology 198 (3), 1172-1182, 2017
432017
The system can't perform the operation now. Try again later.
Articles 1–20